المؤلفون: Aravind Dilli Babu, Sahib Singh, Anjani Thota, Sanchit Duhan, Chiranjeevi Sainatham, Haroon Gill, Lekshminarayan Raghavakurup, Udaya Tantry, Kevin Bliden, Paul Gurbel

المصدر: International Journal of Cardiology: Heart & Vasculature, Vol 52, Iss , Pp 101415- (2024)

مصطلحات موضوعية: Hypertension, VEGFR inhibitor, Axitinib, Cancer, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352906724000812; https://doaj.org/toc/2352-9067

URL الوصول: https://doaj.org/article/11edc5f594224771b9fdcf5d09c14cb8

المؤلفون: Lan Deng, Lihua Wang, Jinzhao Zhang, Le Zhao, Yun Meng, Jidai Zheng, Wei Xu, Zhenping Zhu, Haomin Huang

المصدر: Heliyon, Vol 9, Iss 6, Pp e16922- (2023)

مصطلحات موضوعية: EGFR, VEGF, Biodistribution, VEGFR inhibitor, Endocytosis, Anticancer therapy, Science (General), Q1-390, Social sciences (General), H1-99

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844023041294; https://doaj.org/toc/2405-8440

URL الوصول: https://doaj.org/article/82293986e91e43e1aa68f9797c173238

المؤلفون: Daud, Adil, Kluger, Harriet M, Kurzrock, Razelle, Schimmoller, Frauke, Weitzman, Aaron L, Samuel, Thomas A, Moussa, Ali H, Gordon, Michael S, Shapiro, Geoffrey I

المصدر: British journal of cancer. 116(4)

مصطلحات موضوعية: Humans, Melanoma, Uveal Neoplasms, Skin Neoplasms, Neoplasm Metastasis, Anilides, Pyridines, Receptors, Vascular Endothelial Growth Factor, Antineoplastic Agents, Withholding Treatment, Survival Analysis, Adult, Aged, Aged, 80 and over, Middle Aged, United States, Israel, Belgium, Female, Male, Proto-Oncogene Proteins c-met, cabozantinib, metastatic melanoma, uveal melanoma, vascular endothelial growth factor receptor, MET/VEGFR inhibitor, bone metastases, Receptors, Vascular Endothelial Growth Factor, and over, Oncology & Carcinogenesis, Oncology and Carcinogenesis, Public Health and Health Services

URL الوصول: https://escholarship.org/uc/item/51x6k09n

المؤلفون: Long J, Zhang Y, Huang X, Ren J, Zhong P, Wang B

المصدر: Drug Design, Development and Therapy, Vol Volume 15, Pp 75-85 (2021)

مصطلحات موضوعية: vestibular schwannomas, drug therapy, therapeutic targets, vegfr inhibitor, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/a-review-of-drug-therapy-in-vestibular-schwannoma-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881

URL الوصول: https://doaj.org/article/a1a0ed5c8bc14213841274226f25384e

المؤلفون: Jones, Daniel T., Cruz, Gabriel, Lugue, Maria Theresa, Heer, Manvir S., Sai, Marlai, Pace, Christopher, Bui, Linsey, Silver, Scott A.

المصدر: Student Publications

مصطلحات موضوعية: chemotherapy, targeted therapy, VEGFR inhibitor, cerebellar hemorrhage, side effects, fruzaqla, fruquintinib, metastatic colorectal cancer (MCRC), metastatic colorectal adenocarcinoma

وصف الملف: application/pdf

Relation: https://digitalcommons.kansascity.edu/studentpub/856; https://digitalcommons.kansascity.edu/context/studentpub/article/1855/viewcontent/290875_fruquintinib_induced_cerebellar_hemorrhage_in_left_sided_descending_metastatic_colorectal_adenocarcinoma_a_case_report_and_risk_assessment.pdf

الاتاحة: https://digitalcommons.kansascity.edu/studentpub/856
https://doi.org/10.7759/cureus.68203
https://digitalcommons.kansascity.edu/context/studentpub/article/1855/viewcontent/290875_fruquintinib_induced_cerebellar_hemorrhage_in_left_sided_descending_metastatic_colorectal_adenocarcinoma_a_case_report_and_risk_assessment.pdf

المؤلفون: Bono, Petri, Massard, Christophe, Peltola, Katriina J., Azaro, Analia, Italiano, Antoine, Kristeleit, Rebecca S., Curigliano, Giuseppe, Lassen, Ulrik, Arkenau, Hendrik-Tobias, Hakulinen, Pasi, Garratt, Chris, Ikonen, Tarja, Mustonen, Mika V. J., Rodon, Jordi A.

المساهمون: HUS Comprehensive Cancer Center, Heikki Joensuu / Principal Investigator, Department of Oncology, Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Clinicum, Helsinki University Hospital Area

مصطلحات موضوعية: ODM-203, dose escalation study, phase I, solid tumours, FGFR and VEGFR inhibitor, ENDOTHELIAL GROWTH-FACTOR, PROGNOSTIC-SIGNIFICANCE, INHIBITOR, VEGF, Cancers

وصف الملف: application/pdf

Relation: The study was sponsored by Orion Corporation, Orion Pharma, Espoo, Finland.; Bono , P , Massard , C , Peltola , K J , Azaro , A , Italiano , A , Kristeleit , R S , Curigliano , G , Lassen , U , Arkenau , H-T , Hakulinen , P , Garratt , C , Ikonen , T , Mustonen , M V J & Rodon , J A 2020 , ' Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours ' , ESMO open , vol. 5 , no. 6 , 001081 . https://doi.org/10.1136/esmoopen-2020-001081; http://hdl.handle.net/10138/324382; 98f21a47-b49b-43b7-b3d1-eb1e856f5e79; 000597167800002

الاتاحة: http://hdl.handle.net/10138/324382

المؤلفون: Bono P., Massard C., Peltola K. J., Azaro A., Italiano A., Kristeleit R. S., Curigliano G., Lassen U., Arkenau H. -T., Hakulinen P., Garratt C., Ikonen T., Mustonen M. V. J., Rodon J. A.

المساهمون: P. Bono, C. Massard, K.J. Peltola, A. Azaro, A. Italiano, R.S. Kristeleit, G. Curigliano, U. Lassen, H.-. Arkenau, P. Hakulinen, C. Garratt, T. Ikonen, M.V.J. Mustonen, J.A. Rodon

مصطلحات موضوعية: dose escalation study, FGFR and VEGFR inhibitor, ODM-203, phase I, solid tumours, Settore MED/06 - Oncologia Medica

Relation: info:eu-repo/semantics/altIdentifier/pmid/33262202; info:eu-repo/semantics/altIdentifier/wos/WOS:000597167800002; volume:5; issue:6; firstpage:1; lastpage:11; numberofpages:11; journal:ESMO OPEN; http://hdl.handle.net/2434/824926; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85097034289

الاتاحة: http://hdl.handle.net/2434/824926
https://doi.org/10.1136/esmoopen-2020-001081

المؤلفون: Faivre, S., Niccoli, P., Castellano, D., Valle, J. W., Hammel, P., Raoul, J. -L., Vinik, A., Van Cutsem, E., Bang, Yung-Jue, Lee, S. -H., Borbath, I., Lombard-Bohas, C., Metrakos, P., Smith, D., Chen, J. -S., Ruszniewski, P., Seitz, J. -F., Patyna, S., Lu, D. R., Ishak, K. J., Raymond, E.

المساهمون: 방영주, Bang, Yung-Jue

مصطلحات موضوعية: VEGFR inhibitor, antiangiogenics, crossover, rank-preserving structural failure time (RPSFT), blinded independent central review

Relation: Annals of Oncology, Vol.28 No.2, pp.339-343; 41331; https://hdl.handle.net/10371/173146; 2-s2.0-85019549237; https://academic.oup.com/annonc/article/28/2/339/2676883; 000397278300022

الاتاحة: https://hdl.handle.net/10371/173146
https://doi.org/10.1093/annonc/mdw561
https://academic.oup.com/annonc/article/28/2/339/2676883

المؤلفون: Bin Wang, Junwei Ren, Xiang Yang Huang, Yu Zhang, Jianfei Long, Ping Zhong

المصدر: Drug Design, Development and Therapy

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_treatment, Pharmaceutical Science, Antineoplastic Agents, Review, Schwannoma, therapeutic targets, Bioinformatics, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Ototoxicity, Drug Discovery, medicine, Humans, Pharmacology, VEGFR inhibitor, business.industry, Therapeutic effect, Neurotoxicity, Neuroma, Acoustic, medicine.disease, drug therapy, Clinical trial, Radiation therapy, Drug repositioning, 030104 developmental biology, vestibular schwannomas, 030220 oncology & carcinogenesis, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46455b597043c0b0179cd7d56358c13d
https://doi.org/10.2147/dddt.s280069

المؤلفون: Alexandra Drakaki, Simon Chowdhury, Chia-Chi Lin, Daniel Keizman, Michiel S. van der Heijden, Daniel P. Petrylak, Jae-Lyun Lee, Kim N. Chi, Sergio Bracarda, Daniel Castellano, Georgios Gakis, Andrea Necchi, Lajos Géczi, Ulka N. Vaishampayan, Annamaria Zimmermann, Thomas Powles, Conor J. Kirby, Katherine M Bell-McGuinn, Aude Flechon

المساهمون: Drakaki, A., Kirby, C. J., Van Der Heijden, M. S., Petrylak, D. P., Powles, T., Chi, K. N., Flechon, A., Necchi, A., Geczi, L., Lee, J. -L., Gakis, G., Bracarda, S., Chowdhury, S., Lin, C. -C., Keizman, D., Vaishampayan, U. N., Zimmermann, A. H., Bell-Mcguinn, K., Castellano, D., Graduate School

المصدر: Bladder Cancer, 6(1), 43-52. IOS Press

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, ramucirumab, Urology, medicine.medical_treatment, Population, Subgroup analysis, Immune checkpoint inhibitor, Placebo, Ramucirumab, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, education, urothelial carcinoma, education.field_of_study, Chemotherapy, VEGFR inhibitor, Proportional hazards model, business.industry, Hazard ratio, platinum-refractory, 030104 developmental biology, Docetaxel, 030220 oncology & carcinogenesis, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9131c145fbae3b8eeeb9001f6d11400d
http://www.scopus.com/inward/record.url?scp=85083061281&partnerID=8YFLogxK

المؤلفون: Kelly M. Gaertner, Stephen H. Caldwell, Osama eRahma

المصدر: Frontiers in Oncology, Vol 4 (2014)

مصطلحات موضوعية: Hepatocellular Carcinoma, Sorafenib, Retinal tear, VEGFR inhibitor, Angiogenesis inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00196/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/94badede62b246fda52cf2cd324af421

المؤلفون: Tao Chen, Zhenyu Ding, Yang Wang, Xiawei Wei, Guihong Liu, Yuquan Wei

المصدر: Cell Proliferation

مصطلحات موضوعية: Vascular Endothelial Growth Factor A, 0301 basic medicine, animal structures, Angiogenesis, VEGF receptors, medicine.medical_treatment, Reviews, Angiogenesis Inhibitors, Review, Fibroblast growth factor, Polymorphism, Single Nucleotide, Targeted therapy, 03 medical and health sciences, chemistry.chemical_compound, FGFR/VEGFR inhibitor, 0302 clinical medicine, Neoplasms, fibroblast growth factor, Humans, Medicine, vascular endothelial growth factor, biology, business.industry, Antibodies, Monoclonal, Cell Biology, General Medicine, Receptors, Fibroblast Growth Factor, Hedgehog signaling pathway, Fibroblast Growth Factors, Vascular endothelial growth factor, Receptors, Vascular Endothelial Growth Factor, 030104 developmental biology, Signalling, chemistry, Fibroblast growth factor receptor, 030220 oncology & carcinogenesis, fibroblast growth factor receptor, embryonic structures, Cancer research, biology.protein, biological phenomena, cell phenomena, and immunity, business, vascular endothelial growth factor receptor, Signal Transduction

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1246f8e48f0f0977fc756067c5a0058
https://doi.org/10.1111/cpr.13009

المؤلفون: R. Pirker

المصدر: Journal of Thoracic Oncology. 16:S99-S100

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, business.industry, VEGFR Inhibitor, Cancer research, medicine, Lung cancer, medicine.disease, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::57688531914d8785b14361dfb0ba4084
https://doi.org/10.1016/j.jtho.2021.01.162

المؤلفون: Drakaki A., Kirby C. J., Van Der Heijden M. S., Petrylak D. P., Powles T., Chi K. N., Flechon A., Necchi A., Geczi L., Lee J. -L., Gakis G., Bracarda S., Chowdhury S., Lin C. -C., Keizman D., Vaishampayan U. N., Zimmermann A. H., Bell-Mcguinn K., Castellano D.

المساهمون: Drakaki, A., Kirby, C. J., Van Der Heijden, M. S., Petrylak, D. P., Powles, T., Chi, K. N., Flechon, A., Necchi, A., Geczi, L., Lee, J. -L., Gakis, G., Bracarda, S., Chowdhury, S., Lin, C. -C., Keizman, D., Vaishampayan, U. N., Zimmermann, A. H., Bell-Mcguinn, K., Castellano, D.

مصطلحات موضوعية: Immune checkpoint inhibitor, platinum-refractory, ramucirumab, urothelial carcinoma, VEGFR inhibitor

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000523301600005; volume:6; issue:1; firstpage:43; lastpage:52; numberofpages:10; journal:BLADDER CANCER; http://hdl.handle.net/20.500.11768/118346

الاتاحة: https://hdl.handle.net/20.500.11768/118346
https://doi.org/10.3233/BLC-190252

المؤلفون: Justyna Wierzbicka, F.P. Beserra, Anna Piotrowska, Michal A. Zmijewski

المصدر: Journal of Investigative Dermatology. 141:S199

مصطلحات موضوعية: biology, Chemistry, VEGF receptors, VEGFR Inhibitor, Cell Biology, Dermatology, Biochemistry, Cediranib, Cancer research, biology.protein, Vitamin D and neurology, medicine, Human melanoma, Molecular Biology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::080334c32abc16ff4403653c557515b9
https://doi.org/10.1016/j.jid.2021.08.300

المؤلفون: Mark L. Webb, Mario E. Lacouture, Elaine T. Lam, Anisha B. Patel, Benjamin H. Kaffenberger, Jennifer N. Choi, Robert Claude Tyler, Juegang Ju, Nicholas J. Vogelzang, Jie Luo, Hong Tang, Milan J. Anadkat, Omkar Subhash Marathe

المصدر: Journal of Clinical Oncology. 39:TPS12132-TPS12132

مصطلحات موضوعية: Cancer Research, business.industry, Vascular Endothelial Growth Factor Receptor, VEGFR Inhibitor, Phases of clinical research, Cancer, medicine.disease, Skin reaction, Oncology, medicine, Cancer research, business, Tyrosine kinase, Foot (unit)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::28e9f82f38ff91962a5034571003f5d3
https://doi.org/10.1200/jco.2021.39.15_suppl.tps12132

المؤلفون: Jieer Ying, Jin Li, Weijie Zhang, Panfeng Tan, Wensheng Qiu, Yanqiao Zhang, Yang Luo, Hongyan Yin, Yueyin Pan, Weiguo Su, Hui Zhou, Yan Wang, Ye Guo

المصدر: Journal of Clinical Oncology. 39:2514-2514

مصطلحات موضوعية: Oncology, Advanced colorectal cancer, Cancer Research, medicine.medical_specialty, Fruquintinib, business.industry, Internal medicine, VEGFR Inhibitor, medicine, In patient, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1a64589b269d287adce68318d2e02f69
https://doi.org/10.1200/jco.2021.39.15_suppl.2514

المؤلفون: Thomas E. Hutson, Sumanta K. Pal, Bernard Escudier, Brian I. Rini, Elena Verzoni, Michael B. Atkins, Camillo Porta, David F. McDermott, Michael N. Needle

المصدر: Journal of Clinical Oncology. 38:5062-5062

مصطلحات موضوعية: Oncology, Sorafenib, Cancer Research, medicine.medical_specialty, Tivozanib, business.industry, VEGFR Inhibitor, Phases of clinical research, medicine.disease, Highly selective, 03 medical and health sciences, 0302 clinical medicine, Open label study, Renal cell carcinoma, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::df991a099e8dadd999e504f7ca22686a
https://doi.org/10.1200/jco.2020.38.15_suppl.5062

المؤلفون: Rongrong Li, Guopei Zhu, Liang Zhang, Shengjin Dou

المصدر: International Journal of Radiation Oncology*Biology*Physics. 100:1378-1379

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Radiation, Adenoid cystic carcinoma, business.industry, VEGFR Inhibitor, Phases of clinical research, medicine.disease, chemistry.chemical_compound, chemistry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Apatinib, In patient, Head and neck, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a902e8b1a1812c07a062cc23e7cf1fbf
https://doi.org/10.1016/j.ijrobp.2017.12.184

المؤلفون: Sheng Zhang, Fei Liang

المصدر: Journal of Clinical Oncology. 37:TPS538-TPS538

مصطلحات موضوعية: Cancer Research, biology, business.industry, VEGF receptors, VEGFR Inhibitor, Phases of clinical research, Metastatic gastric cancer, chemistry.chemical_compound, Oncology, chemistry, Cancer research, biology.protein, Medicine, Apatinib, business, Metastatic Penile Cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f33c134f0da736ba306b90947fa324b4
https://doi.org/10.1200/jco.2019.37.7_suppl.tps538